Malignant Neoplasm of Stomach Not Yet Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Cancer, Gastric / Gastric Malignancies / Stomach Cancer / Gastric Cancers / Gastric Cancer / Gastric malignancy / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04363801A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal CancerTreatment
NCT04367025Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric CancerTreatment
NCT04202484Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction AdenocarcinomaTreatment
NCT03950271SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction AdenocarcinomaTreatment
NCT04149015Neoadjuvant POF in the Treatment of Locally Advanced Gastric CancerTreatment
NCT02949258Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric CancerTreatment
NCT02623153Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric CancerTreatment